Is boceprevir fda approved?
On 13 May 2011, the FDA approved boceprevir (Victrelis) to be used in combination with peginterferon alfa and ribavirin to treat hepatitis C genotype 1. Boceprevir is the first direct acting antiviral DAA) against the hepatitis C virus to be approved.
How is boceprevir used?
Boceprevir is used along with two other medications (ribavirin [Copegus, Rebetol] and peginterferon alfa [Pegasys]) to treat chronic hepatitis C (an ongoing viral infection that damages the liver) in people who have not yet been treated for this condition or whose condition did not improve when they were treated with …
What are protease inhibitors used to treat?
Protease inhibitors, which figure among the key drugs used to treat HIV, work by binding to proteolytic enzymes (proteases). That blocks their ability to function. Protease inhibitors don’t cure HIV. But by blocking proteases, they can stop HIV from reproducing itself.
Why do we use protease inhibitors?
Protease inhibitors are medications that help slow the progression of HIV. They do this by blocking the enzyme “protease,” which HIV cells need to develop and mature. Blocking protease prevents the virus from making copies of itself. Protease inhibitors are a type of antiretroviral therapy (ART) medication.
What drug company makes ribavirin?
Introduction. Film coated ribavirin tablets has developed by Roche for the treatment of patients with chronic hepatitis C in combination with peginterferon alfa-2a or sofosbuvir.
What does ribavirin do to the body?
Ribavirin is in a class of antiviral medications called nucleoside analogues. It works by stopping the virus that causes hepatitis C from spreading inside the body.
Which drugs are protease inhibitors?
There are ten HIV protease inhibitors approved by the FDA; those inhibitors include: saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, fosamprenavir, lopinavir, atazanavir, tipranavir, and darunavir (Figure 2).
What is another name for ribavirin?
Ribavirin is available under the following different brand names: Rebetol, Ribasphere, RibaPak, Copegus, Virazole, and Moderiba.